@retinai.com
RetinAI develops solutions to â¨generate and organize â¨insights and knowledge to improve patient outcomes.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
RetinAI is a leading brand in developing software solutions that generate and organize insights and knowledge to improve patient outcomes. They offer end-to-end digital solutions that accelerate the research and development of first-in-human drug candidates, enhance clinical studies, and elevate the quality of care for patients. Their wide range of products includes Discovery UNITY, Discovery for Clinical Studies, Discovery CORE Apps for clinics, Precision medicine, and Real world evidence.
These solutions cater to the needs of various sectors, including Life Sciences & Pharma, Clinics & Hospitals, and Device Manufacturers. RetinAI is committed to enabling the right decisions in clinics, research, and pharma. By harmonizing and aggregating unstructured medical data at scale, they create a frictionless and open data ecosystem that enhances understanding of patients' diseases and outcomes through actionable insights and knowledge.
Founded in 2017 by Carlos Ciller, Stefanos Apostolopoulos, and Sandro De Zanet, RetinAI has achieved significant milestones, including FDA clearance for RetinAI Discovery and CE marking certification for Discovery as a Class IIa Medical Device. They have collaborated with renowned organizations like Novartis and have garnered recognition through peer-reviewed research publications. With a customer satisfaction rate of 99%, RetinAI is dedicated to revolutionizing healthcare through innovative software solutions.
Contact them today to unlock the full potential of data-driven decision-making in healthcare
Company Type
Privately Held
Company Size
11-50
Year Founded
2017
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online